Literature DB >> 3039054

Virus-specific factors in experimental Argentine hemorrhagic fever in rhesus macaques.

K T McKee, B G Mahlandt, J I Maiztegui, D E Green, C J Peters.   

Abstract

A nonhuman primate model for Argentine hemorrhagic fever has been developed that closely mimics the human clinical syndrome. Parenteral infection of adult Macaca mulatta with low-passage isolates of two Junin viral strains resulted in distinctive hemorrhagic or neurological disease in rhesus macaques that correlated with clinical illness patterns present in the humans from whom the viral strains were obtained. Transient leukopenia, together with thrombocytopenia and secondary bacterial septicemia, were documented among animals infected with both viral strains. In contrast, differing patterns of viremia, oropharyngeal viral shedding, and antibody response occurred in the two virus-infected groups. These results, together with postmortem virologic and histopathologic findings, suggest that viral-strain-specific factors are important determinants of clinical disease patterns in this model system.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3039054     DOI: 10.1002/jmv.1890220202

Source DB:  PubMed          Journal:  J Med Virol        ISSN: 0146-6615            Impact factor:   2.327


  13 in total

Review 1.  Epidemiology and pathogenesis of Bolivian hemorrhagic fever.

Authors:  Michael Patterson; Ashley Grant; Slobodan Paessler
Journal:  Curr Opin Virol       Date:  2014-03-15       Impact factor: 7.090

2.  Guinea Pig Transferrin Receptor 1 Mediates Cellular Entry of Junín Virus and Other Pathogenic New World Arenaviruses.

Authors:  Brady T Hickerson; Jonna B Westover; Zhongde Wang; Young-Min Lee; Brian B Gowen
Journal:  J Virol       Date:  2020-01-31       Impact factor: 5.103

3.  Highly Pathogenic New World and Old World Human Arenaviruses Induce Distinct Interferon Responses in Human Cells.

Authors:  Cheng Huang; Olga A Kolokoltsova; Nadezhda E Yun; Alexey V Seregin; Shannon Ronca; Takaaki Koma; Slobodan Paessler
Journal:  J Virol       Date:  2015-04-29       Impact factor: 5.103

Review 4.  Lymphocytic choriomeningitis virus (LCMV) infection of macaques: a model for Lassa fever.

Authors:  Juan C Zapata; C David Pauza; Mahmoud M Djavani; Juan D Rodas; Dmitry Moshkoff; Joseph Bryant; Eugene Ateh; Cybele Garcia; Igor S Lukashevich; Maria S Salvato
Journal:  Antiviral Res       Date:  2011-07-27       Impact factor: 5.970

5.  Ribavirin prophylaxis and therapy for experimental argentine hemorrhagic fever.

Authors:  K T McKee; J W Huggins; C J Trahan; B G Mahlandt
Journal:  Antimicrob Agents Chemother       Date:  1988-09       Impact factor: 5.191

6.  Pathogenesis of XJ and Romero strains of Junin virus in two strains of guinea pigs.

Authors:  Nadezhda E Yun; Nathaniel S Linde; Natallia Dziuba; Michele A Zacks; Jeanon N Smith; Jennifer K Smith; Judy F Aronson; Olga V Chumakova; Heather M Lander; Clarence J Peters; Slobodan Paessler
Journal:  Am J Trop Med Hyg       Date:  2008-08       Impact factor: 2.345

Review 7.  Junín virus pathogenesis and virus replication.

Authors:  Ashley Grant; Alexey Seregin; Cheng Huang; Olga Kolokoltsova; Allan Brasier; Clarence Peters; Slobodan Paessler
Journal:  Viruses       Date:  2012-10-19       Impact factor: 5.048

8.  Lymphocytic choriomeningitis virus infection in FVB mouse produces hemorrhagic disease.

Authors:  Frederick J Schnell; Sarah Sundholm; Stacy Crumley; Patrick L Iversen; Dan V Mourich
Journal:  PLoS Pathog       Date:  2012-12-27       Impact factor: 6.823

9.  Treatment of late stage disease in a model of arenaviral hemorrhagic fever: T-705 efficacy and reduced toxicity suggests an alternative to ribavirin.

Authors:  Brian B Gowen; Donald F Smee; Min-Hui Wong; Jeffery O Hall; Kie-Hoon Jung; Kevin W Bailey; John R Stevens; Yousuke Furuta; John D Morrey
Journal:  PLoS One       Date:  2008-11-14       Impact factor: 3.240

Review 10.  Animal Models for the Study of Rodent-Borne Hemorrhagic Fever Viruses: Arenaviruses and Hantaviruses.

Authors:  Joseph W Golden; Christopher D Hammerbeck; Eric M Mucker; Rebecca L Brocato
Journal:  Biomed Res Int       Date:  2015-07-21       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.